Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main goal of this study is to examine how sex hormones and low energy availability affect the concentrations of bone remodelling markers at rest and after a running protocol. The research questions to be addressed are:
1: Does the ovarian hormone profile influence serum bone marker concentrations in women exercising resting and in response to to exercise?
2. Are there differences in response to low energy availability in bone marker concentrations between eumenorrhoeic female athletes and oral contraceptive users?
3: Is the response of bone markers affected by different exercise stimuli: endurance or aerobic endurance?
4: Do bone markers return to baseline levels after 24 hours of high energy availability diet after 6 days of low energy availability?
To achieve the aim of the study, there will be two experimental groups - e.g. eumenorrhoeic females and oral contraceptive users - who, after screening, will be randomly assigned to a low- or high-energy diet. After 6 days on this diet, the participant will undergo an intervallic running protocol and blood samples will be taken before and after the test. The following month the participant will do the other type of diet.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Eumhenorreic females | Experimental |
| |
| Oral concetraceptive users | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Low energy availability | Other | Participants follow 6 days of a low-energy availability diet. The kilocalories of each diet are prescribed individually based on their fat-free mass. |
| Measure | Description | Time Frame |
|---|---|---|
| Concentration of bone metabolism biomarkers | Concentration of procollagen type I N-propeptide (P1NP), cross-linking telopeptide of type I collagen (βCTX-1), paratyroid hormone, calcium, sclerostin, osteoprotegin, osteocalcin, bone alkaline phospatase, Receptor Activator for Nuclear Factor κ B Ligand (RANKL) measured in serum samples. | immediately pre-exercise and immediately, 15 minutes and 24 hours post-exercise |
| Concentrations of other biochemical biomarkers | Concentrations of Triiodothyronine (T3), Albumin, Sex Hormone Binding Globulin (SHBG), etc. measured in serum | Immediately pre-exercise and immediately, 15 minutes and 24 hours post-exercise |
| Concentrations of sex hormones | Concentrations of 17β-Oestradiol and Progesterone measured in serum. | Immediately pre-exercise and immediately, 15 minutes and 24 hours post-exercise |
| Bone mineral density | Total, lumbar spine and femoral neck bone mineral density (g/cm^2) measured by dual x-ray absorptiometry | At the screening phase |
| Measure | Description | Time Frame |
|---|---|---|
| Training status variables | Oxygen uptake at ventilatory threshold 1, ventilatory threshold 2, and maximal oxygen uptake (ml/kg/min) measured with a gas analyser. | At the screening phase |
| Body composition variables |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Faculty of physical activity and sport sciences | Madrid | Comunity of Madrid | 28040 | Spain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| High energy availability | Other | Participants follow 6 days of a high-energy availability diet. The kilocalories of each diet are prescribed individually based on their fat-free mass. |
|
Fat mass (kg), fat free mass (kg), fat mass percentage, fat-free mass percentage (FFM), total mass (kg) measured by dual x-ray absorptiometry
| Immediately pre- and post-nutritional intervention (bioimpedance) and DXA at the screening |
| Body metrics | Height (cm) | Measured at the screening phase |